The networking session with Eur. Fdn. for the Study of Chronic Liver Failure will start soon! Head over Track Hub 4 (Cirrhosis & Complications) at 13:30! Meet Paolo Angeli, Anna Bosch, Joan Clària, Hannelie Korf, Richard Moreau, & Cristina Sánchez-Garrido! #EASLCongress

Thank you to everyone who stopped by our Track Hub today at #EASLCongress 2025! We're grateful for your time, curiosity, and thoughtful questions. Let’s keep the conversation going and shape the future of #chronicliverdisease research together.

To everyone involved in the #CHANCE study: Join us today for our 8th CHANCE Investigator Meeting @ #EASLCongress 2025 Non-industry Meeting Room 1 (Level 2). We'll share results, the publications plan, and how to submit ancillary studies. Looking forward to seeing you all there!

This p.m. at the EASLnews-CLIF-C General Assembly, our General Manager shared highlights of 2024, followed by presentations on the #ACLF diagnosis harmonization survey, the CLIF-The Baveno Cooperation: an EASL Consortium joint project on natural history of compensated #cirrhosis, and our new training program.

Kicking off our #EASL2025 Networking Session with an intro to the DECISION project by Pierre-Emmanuel Rautou - Let’s talk systems medicine, cirrhosis, and precision care! Rautou Pierre-Emmanuel Eur. Fdn. for the Study of Chronic Liver Failure EASLnews #LiverDisease

Lastly at DECISION's Networking Session, Richard Moreau shares new data: high-throughput omics reveals biomarkers for infection & poor outcomes in cirrhosis. Eur. Fdn. for the Study of Chronic Liver Failure Inserm EASLnews #Metabolomics #Cytokinomics #EASL2025

Greetings from the DECISION Investigator Meeting at #EASL2025: Study updates and collaborative discussions with Paolo Caraceni & Pierre-Emmanuel Rautou EASLnews Eur. Fdn. for the Study of Chronic Liver Failure

Don't miss Thierry Gustot, Principal Investigator of the #CHANCE study and Vice-Chair of the EASLnews-CLIF Consortium Steering Committee at #EASLCongress 2025 on one-week criteria of potential care inappropriateness for patients w/#ACLF not eligible for #livertransplantation

5/ Two fantastic studies from Argentina: 🫀NT-proBNP predicts ACLF & mortality in LT candidates 🇦🇷 🦠 Torque Teno Virus as biomarker of immune status in liver transplant recipients 🇦🇷 Manuel Mendizabal Juan Manuel Díaz, MD, MSc Eur. Fdn. for the Study of Chronic Liver Failure

Reflections after another inspiring #EASL2025 Congress in Amsterdam EASLnews EASL Education Eur. Fdn. for the Study of Chronic Liver Failure GENFIT IDIBAPS Hospital Clínic Liver Transplantation Journal (LTxJournal) linkedin.com/posts/juan-man…

Get an inside look at the progress, partnerships, and breakthroughs shaping the future of #chronicliverdisease research in our annual report 2024. Dive in! view.genially.com/67f614412f5bd2…

Our Master program bridges the gap between cutting-edge #hepatologyresearch and real-world #clinicalcare. Hear from Paolo Angeli about everything it covers. Enrollment opens in July! Tell us: What do you hope to gain from this program?

Our Master program bridges clinical insight and research excellence. Hear Richard Moreau introduce Foundations and Management of #ChronicLiverDisease—a must for future hepatology researchers. Pre-registration opens in July! What would you hope to learn?

🎥 New keynote online! Prof. Richard Moreau, Director of Eur. Fdn. for the Study of Chronic Liver Failure, explores immune dysfunction in AD & #ACLF and suggests a common mechanism behind inflammation & immune deficiency. Watch now 👉 youtu.be/KWoUbTsNjQM #LiverTwitter #Hepatology

Thinking about advancing your career in hepatology research? Get a closer look at our Master Program — from course structure to expert instructors. Pre-registration opens in July! Request more info today: forms.office.com/e/M2p4YGNjFv

🔥 We’ve hit 50% recruitment in the #COMBATtrial! Huge thanks to all involved!💙 Rautou Pierre-Emmanuel Eur. Fdn. for the Study of Chronic Liver Failure Hospital Clínic Liver ICU Uniklinik RWTH AC Università di Bologna Giacomo Zaccherini Agustín Albillos Università di Torino Vall d'Hebron Institut de Recerca Assistance Publique – Hôpitaux de Paris (AP-HP) Uniklinik Münster MedB Lab Frank Uschner rajmookerjee #LiverTwitter #ACLF #ClinicalTrials

The leadership and coordination teams are currently working on the first core publication from the CHANCE study, which will focus on key clinical endpoints and early findings efclif.com/news/chance-st…

Patient recruitment update: Enrollment ongoing for #CHANCE phase 2 to define futility criteria for #livertransplant in severe #ACLF. Of 98 patients recruited from 17 hospitals across Europe, Latin America, and North America, 56 have been transplanted and 42 are on waiting list.

Ready to take your next career step in liver disease research? Prof. Jonel Trebicka introduces #ClinicalResearch in #Hepatology, a specialization in our new Master program. Want to learn more? Fill out the form forms.office.com/e/M2p4YGNjFv and we’ll provide you with more details.

Eur. Fdn. for the Study of Chronic Liver Failure Advanced Training Course on Research in #Hepatology #LiverDisease #ACLF